Head of Equity Strategy, Saxo Bank Group
Summary: The US-China trade war shows no signs of cooling off after Washington's latest broadside against Chinese technology giant Huawei.
Google responded today, freezing Huawei smartphones' access to certain Google apps. Existing users will receive security fixes and access to some apps, Huawei users may be excluded entirely when the new Android operating system is rolled out later this year. In addition, Qualcomm, Xilinx and Broadcom will also stop supplying Huawei with hardware, hampering Huawei’s ability to deploy 5G internationally. This is effectively the starting signal of a technology Cold War. The Chinese government has still not retaliated for the actions against Huawei, but we expect its response to be proportional.
Global supply chain under attack
What we are witnessing is a potential reconfiguration of global trade as it has stood since World War II. The World Trade Organization has been put under pressure by Trump's threatening a US withdrawal unless WTO terms are changed; Washington also blocked judicial appointments at the WTO’s appellate body.
The upcoming G20 meeting in Osaka had a specific agenda regarding WTO and global trade but with the US-China trade war escalating, the focus is now entirely on the rumoured meeting between Trump and Chinese president Xi Jinping. CPB’s estimate on world trade volume is down 3.5% since October 2018, with this marking the largest decline since 2008 as global trade slows down on worsening economic activity as well as friction from tariffs.
US companies with significant revenue exposure to Greater China (both the mainland and Hong Kong) are the ones facing the most downside risk from any further escalation of the trade war. In the very short term, Apple is a likely candidate for direct retaliation from Beijing due to the US government's Huawei ban. Apple gets around 20% of its revenue ($52 billion in FY'18) from Greater China and thus has the most nominal revenue exposure of any US company.
The table below shows the 33 companies with the largest revenue exposure to Greater China. Major corporate brands that are most likely to be exposed are highlighted in orange.
Rare earth minerals
Outside of the direct US-China technology conflict, China holds a “nuclear option” against the US as it controls 85% of the global rare earths industry. Rare earth minerals are critical to electronics (rechargeable batteries, smartphones, catalytic converters, magnets, fluorescent lighting, et cetera) and critical defense (night-vision goggles, precision-guided weapons, GPS equipment, and similar).
Lynas is the biggest privately-owned rare-earth miner controlling around 10% of the global market. We made an investment recommendation on Lynas back in September 2018 and updated it in March as Wesfarmers announced an acquisition bid for Lynas.
Will the CNH be allowed to go?
Another potential lever for China is its currency. Weakening the CNH against the dollar could offset weakness coming from US tariffs. Indeed, the USDCNH has moved significantly closer to the 7.0000 level long assumed to be the upper limit of Beijing's tolerance due to the signaling value related to currency manipulation. Given the additional tariffs levied by the US, USDCNH should most likely trade above 7.0000 and if this happens it will be a game-changer for financial markets. Equities would likely tumble and the JPY would see significant gains.
Emerging market equities scream 'sell!'
Emerging markets have declined almost 10% in just four weeks and we expect this trend to grow much worse given the current trajectory of the US-China trade headlines. Our tactical asset allocation view is to be underweight emerging markets. It also seems that the market is the least complacent on direct and indirect exposures to China, so the best way to express negative views on trade is via emerging market equities, KRW, JPY, oil, Australian equities and bunds.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)